Antibody Based Therapy in Coronary Artery Disease and Heart Failure
Journal Title: Heart Research – Open Journal - Year 2017, Vol 4, Issue 2
Abstract
The function of the immune system is to protect the host against disease. Antibodies are a key part of the adaptive response, recognising specific antigens and invading pathogens and marking them for destruction or blocking their activities. A mechanistic and molecular understanding of this process has allowed researchers to harness their natural function. They are now routinely used as a diagnostic tool in the clinic and in research to investigate pathological signalling. More recently, antibodies have been utilised for another application – therapy. Antibody based therapy is one of the newest and fastest growing with nearly 70 approved drugs to date and over 1000 in clinical trials. Investment from the pharmaceutical sector shows no signs of abating and this technology is now widely accepted for treating cancer, autoimmune and infectious diseases. In the context of the cardiovascular system however, antibody therapies are relatively limited. This review summarises the monoclonal antibodies approved for clinical use or currently in clinical trials for treating cardiovascular disorders. Presently, coronary artery disease, heart failure and transplant are the main indications, and monoclonal antibody therapies are discussed in the context of their specific applications.
Authors and Affiliations
Lorna R. Fiedler
Interpretation of Heart Sound Signal through Automated Artifact-Free Segmentation
Purpose: Digital recording of heart sounds commonly known as Phonocardiogram (PCG) signal, is a convenient primary diagnostic tool for analyzing condition of heart. Phonocardiogram aids physicians to visualize the acoust...
Pharmacological Agents in the Clinic: Trial and Error
Following an explosion of molecular and cellular research in the last 50 years, the study of specific molecular targets in the context of heart failure has generated much excitement. With the incidence of heart failure r...
Nicorandil: What is Beyond the Anti-Anginal Action?
Incidence of Contrast Induced Nephropathy (CIN) among ischemic heart disease patients subjected to coronary catheterization is highly dependent on the kidney function before contrast media administration and relevant ris...
Treatment of Cardiac Hemochromatosis
Treatment of iron-overload states is important to prevent or reverse cardiac dysfunction.1-5 Removal of excess iron from the tissues in these patients reduces generation of free radicals, decreasing organ damage.6,7 Remo...
Gangrene of the Left Forearm Following Septicaemia in a Nigerian Child With Tetralogy of Fallot: A Case Report
Tetralogy of Fallot (TOF) carries a higher risk for infective endocarditis (IE) due to associate multiple cardiac lesions. The incidence of IE in operated TOF patients either by corrective or palliative surgery is high (...